Revance Therapeutics Inc (NASDAQ:RVNC)

26.36
BATS BZX Real-Time Price
As of 11:43am ET
 +0.67 / +2.61%
Today’s Change
11.27
Today|||52-Week Range
29.51
+61.52%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Foley Mark J
President & Chief Executive Officer
Sale10/13/202142,096$23.08$971.6K+11.22%
Foley Mark J
Chief Executive Officer
Buy11/29/202140,000$12.90$516.0K+106.02%
Rankin Aubrey
Buy12/03/202130,000$14.43$432.9K+75.82%
Moxie Dwight
Secretary, Senior Vice President & General Counsel
Sale9/14/202211,000$27.07$297.8K-6.76%
Russell Angus C
Director
Buy12/13/20216,400$15.74$100.7K+65.08%
Schilke Tobin C
Chief Financial Officer
Sale12/15/20211,556$15.92$24.8K+61.24%
Sjuts Dustin S
President
Gift6/30/20221,000$11.75$11.8K+85.75%
Foley Mark J
Chief Executive Officer
Gift6/30/20221,000$11.75$11.8K+85.75%
Schilke Tobin C
Chief Financial Officer
Gift6/30/2022965$11.75$11.3K+85.75%
Sjuts Dustin
President
Sale12/15/2021513$15.92$8.2K+61.24%
Page of 2